Literature DB >> 25557324

Improving our understanding of the use of traditional complementary/alternative medicine in children with cancer.

Elena J Ladas1, Meiko Lin, Federico Antillion, Silvia Rivas, Guillermo Chantada, Walter Cacciavillano, Roberta Ortiz, Katja Stein, Luis Castillo, Valeria Rocha, Ligia Fu, Hilze Rodriquez, Kara M Kelly.   

Abstract

BACKGROUND: Children with cancer in high-income and low-income countries often use traditional complementary/alternative medicine (TCAM). With efforts by the World Health Organization and international twinning programs improving access to conventional care for patients with childhood cancer, understanding the global use of TCAM is important because reliance on TCAM may affect time to presentation, adherence, and abandonment of care. In the current study, the authors describe the process and validation of an international survey documenting the use of TCAM among children with cancer.
METHODS: The survey was designed to collect information on TCAM use and associated factors through both open-ended and close-ended questions. During the period between June 2012 and December 2013, the survey was administered to 300 children and adolescents (or their parents) who were undergoing treatment for cancer at a collaborating institution located in Mexico, Uruguay, and Nicaragua.
RESULTS: For the majority of constructs, the survey demonstrated strong test-retest reliability as evidenced by an intraclass correlation of at least ≥0.79 in each of the participating countries. The survey demonstrated good internal consistency and reliability across countries (α range from. 77 to. 85 for the belief scale; and an α range from. 60 to. 86 for the cause scale) and convergent validity between TCAM beliefs and behavior constructs (adjusted correlation range, 0.35-0.60).
CONCLUSIONS: The results of the current study demonstrate the successful development of a cross-cultural survey that produced results that were reliable and valid. These findings will aid investigators in providing guidelines concerning TCAM, support the development of education and research priorities, and identify variables associated with TCAM that are region-specific.
© 2014 American Cancer Society.

Entities:  

Keywords:  complementary/alternative medicine; pediatric oncology; supportive care; survey design; twinning programs

Mesh:

Year:  2014        PMID: 25557324     DOI: 10.1002/cncr.29212

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Retinoblastoma.

Authors:  Helen Dimaras; Timothy W Corson; David Cobrinik; Abby White; Junyang Zhao; Francis L Munier; David H Abramson; Carol L Shields; Guillermo L Chantada; Festus Njuguna; Brenda L Gallie
Journal:  Nat Rev Dis Primers       Date:  2015-08-27       Impact factor: 52.329

2.  The role of traditional healers in the diagnosis and management of Burkitt lymphoma in Cameroon: understanding the challenges and moving forward.

Authors:  Glenn M Afungchwi; Peter B Hesseling; Elena J Ladas
Journal:  BMC Complement Altern Med       Date:  2017-04-11       Impact factor: 3.659

3.  Caregivers' knowledge and acceptance of complementary and alternative medicine in a tertiary care pediatric hospital.

Authors:  Mehdi Trifa; Dmitry Tumin; Hina Walia; Kathleen L Lemanek; Joseph D Tobias; Tarun Bhalla
Journal:  J Pain Res       Date:  2018-03-01       Impact factor: 3.133

Review 4.  Global Use of Traditional and Complementary Medicine in Childhood Cancer: A Systematic Review.

Authors:  Caroline Diorio; Catherine G Lam; Elena J Ladas; Festus Njuguna; Glenn M Afungchwi; Katherine Taromina; Stacey Marjerrison
Journal:  J Glob Oncol       Date:  2016-11-09

5.  Beliefs and Determinants of Use of Traditional Complementary/Alternative Medicine in Pediatric Patients Who Undergo Treatment for Cancer in South America.

Authors:  Valeria Rocha; Elena J Ladas; Meiko Lin; Walter Cacciavillano; Elizabeth Ginn; Kara M Kelly; Guillermo Chantada; Luis Castillo
Journal:  J Glob Oncol       Date:  2017-02-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.